SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015366
Filing Date
2017-08-03
Accepted
2017-08-03 16:19:46
Documents
61
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20170630.htm 10-Q 1959901
2 EX-31.1 mcrb-ex311_6.htm EX-31.1 11504
3 EX-31.2 mcrb-ex312_7.htm EX-31.2 11467
4 EX-32.1 mcrb-ex321_9.htm EX-32.1 7637
5 EX-32.2 mcrb-ex322_8.htm EX-32.2 7648
  Complete submission text file 0001564590-17-015366.txt   5731788

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20170630.xml EX-101.INS 1249557
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20170630.xsd EX-101.SCH 34925
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20170630_cal.xml EX-101.CAL 35749
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20170630_def.xml EX-101.DEF 79520
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20170630_lab.xml EX-101.LAB 262452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20170630_pre.xml EX-101.PRE 194133
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 171005195
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences